Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ernest Borden"'
Autor:
Kuo Sheng Hsu, Mukesh K. Jain, Yu Liu, Ernest Borden, Ganapati H. Mahabeleshwar, Xuan Zhao, Hung Ying Kao, Dongyin Guan, Xiwen Cheng
Publikováno v:
Journal of Biological Chemistry. 292:10048-10060
IFNs are effective in inhibiting angiogenesis in preclinical models and in treating several angioproliferative disorders. However, the detailed mechanisms of IFNα-mediated anti-angiogenesis are not completely understood. Stat1/2/3 and PML are IFNα
Autor:
Thomas M. Aaberg, Charlotta All-Ericsson, Carryn Anderson, Sophie Bakri, Aubin Balmer, David Sander Bardenstein, Rafael I. Barraquer, Valentina de Belvis, Louise Bergman, Michiel R. de Boer, James P Bolling, Ernest Borden, Norbert Bornfeld, Lex M. Bouter, Julie Bray, Greta R. Bunin, Devron H. Char, Guillermo Luis Chantada, Benson Chen, Patricia Chevez-Barrios, Murali Chintagumpala, Robin Clark, Kimberly Cockerham, Javier Coloma, Sharon Cook, Sarah E. Coupland, Jihan Dennaoui, Karin Dieckmann, Ira J. Dunkel, Omar M Durrani, Jonathan Dutton, Michael A. Dyer, Javier Elizalde, Ralph C. Eagle, Evelyn Fu, Peter Fleming, Robert Folberg, Jill A. Foster, Debra Friedman, Joseph Frucht-Perry, Anat Galor, Roberta E. Gausas, Dan S. Gombos, Evangelos S. Gragoudas, Jennifer Gravette, Carl Groenewald, J. William Harbour, Martin Heur, Joanne Hilden, Paul Hiscott, Santosh Honavar, Jennifer I. Hui, Saskia Marijke Imhof, Martine J. Jager, Bennie H. Jeng, David R. Jordan, Hanneke J.G. Journée-de Korver, Rima F. Jubran, Peter K. Kaiser, Hayyam Kiratli, Tero Kivelä, Stephen R. Klapper, Alfred G. Knudson, Anne Marie Lane, Gerald Langmann, Carlos Leal-Leal, Michael Levien, Hilel Lewis, Karin U. Loeffler, Cari E. Lyle, Roy Ma, Willem Maat, Nancy Mansfield, Eduardo Marback, Anna T. Meadows, Thomas E. Merchant, Edoardo Midena, David Miller, Annette C. Moll, Hardeep Singh Mudhar, Francis Munier, Michael D. Onken, Manuela Orjuela, Lisa Paquette, Michael Andrew Parsons, Bhupendra Patel, Maria Fideliz de la Paz, David Peereboom, Jose Perez-Moreiras, R Poetter, Patrick De Potter, Consuelo Prada, Paul L Proffer, Ian George Rennie, Carlos Rodriguez-Galindo, Geoffrey Edward Rose, Mordechai Rosner, Paul Anthony Rundle, Stefan Sacu, Andrew P. Schachat, Nicoline Elisabeth Schalij-Delfos, Lynn Schoenfield, Ursula Schmidt-Erfurth, Mona Schmutzer, Luann Sculley, Jonathan E. Sears, Stefan Seregard, Rishi P. Singh, Julie Ann Stoner, Mehran Taban, Mehryar Taban, Azzam Taktak, Madhura Tamhankar, Elias I. Traboulsi, Nikolaos Trichopoulos, David T. Tse, Geeta K. Vemuganti, Judith Villablanca, Werner Wackernagel, Allan Wilkinson, Matthew W. Wilson, Leonidas Zografos, Martin Zehetmayer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cea3708546d234d7db80e4b3b3286d73
https://doi.org/10.1016/b978-1-4160-3167-3.50004-8
https://doi.org/10.1016/b978-1-4160-3167-3.50004-8
Autor:
Thomas E, Hutson, Luis, Molto, Tarek, Mekhail, Paul, Elson, James, Finke, Charles, Tannenbaum, Ernest, Borden, Robert, Dreicer, Thomas, Olencki, Ronald M, Bukowski
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 9(4)
The purpose of our study was to determine the maximum tolerated dose (MTD), dose-limiting toxicities, and effects on chemokine/cytokine gene expression in peripheral blood mononuclear cells (PBMCs) of consensus IFN (CIFN).Cohorts of three to six pati
Autor:
I. Bruce Rosenzweig, Ernest Borden, Jacquelyn A. Hank, Paul M. Sondel, Earl S. Shrago, John J. Albers, Janet L. Adolphson, Donald A. Wiebe
Publikováno v:
Biotherapy (Dordrecht, Netherlands). 2(3)
Six patients with confirmed malignant disease received four consecutive weekly cycles of human recombinant interleukin-2 (IL-2) 4 days/week, continuous iv. infusion, 3 X 10(6) U/m2/day. Plasma cholesterol decreased a mean of 7% within 24 hours after
Publikováno v:
Journal of Interferon & Cytokine Research; Aug2009, Vol. 29 Issue 8, p451-460, 10p
Publikováno v:
ResearcherID
Background. Each year, 6000 people die in the United States from metastatic melanoma. Further study of factors affecting the prognosis of patients with this disease is needed. Methods. The authors analyzed response and survival data from 635 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6172e35520dc981c27bb677ce08a5c72
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:A1993LD04100017&KeyUID=WOS:A1993LD04100017
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:A1993LD04100017&KeyUID=WOS:A1993LD04100017